๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

ฮด in Dementia Clinical Trials

RecruitingNAAges 65 Years - 100 YearsAllThe University of Texas Health Science Center at โ€ฆ
NCT05592678 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to demonstrate potential improvements in clinical trial methods relating to dementia and cognitive decline. The main questions it aims to answer are: * Can an intervention's outcome be better assessed by a latent variable ("ฮด") integrating cognitive performance with functional status? * Can latent biomarkers of ฮด guide the selection of an intervention that will modulate dementia severity? * Can a latent variable, derived from information collected remotely from caregivers, preselect subjects most likely to respond to the intervention? * Is the effect of the intervention in fact medicated by changes in the targeted biomarker? In this case, the biomarker will be a latent variable derived from several proteins measured in blood (i.e., so-called "adipokines"). The intervention will be donepezil, a medication approved for the treatment of Alzheimer's Disea

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Ambulatory outpatient volunteers with co-informants. 2. Aged 65-100 years 3. Clinical diagnosis of AD, or MCI. 4. Capacity to give informed consent. 5. GDS score (15 item) โ‰ค 8. 6. No significant visual or hearing impairments 7. Standardized dECog score between 1.0 and 5.0 relative to ADNI's cohort. Exclusion Criteria: 1. A history of psychosis, including visual hallucinations; 2. History or treatment for Parkinson's, or tremor, or Rapid Eye Movement (REM) behavior disorder; 3. History of bradycardia or syncopal events; 4. Treatment for cancer in the last 5 years (excluding skin cancers); 5. Major surgery in the last year; 6. Treatment for a seizure disorder with anticonvulsants; 7. Treatment for agitation or psychosis with neuroleptics (treatment of anxiety or insomnia allowed); 8. Current treatment with donepezil or any other AChEI or exposure within the last six months 9. With a recently started Donepezil Rx (\< 2 weeks), inability to stop Donepezil treatment for 14 days prior to study enrollment. 10. AChEI treatment not appropriate due to negative risk/benefit ratio based on medical Hx and symptoms during screening. Evaluated by PI and referring clinician. 11. Co-participation in another study that the PI feels would pose a safety risk or adversely affect data integrity of this study.
๐Ÿ’Š

What it tests

  • Donepezil
๐Ÿ“

Where

1 site
Univeristy of Texas Health Science Center at San Antonio (UTHSCSA)
San Antonio, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy